848 results on '"Kakeya, Hideaki"'
Search Results
202. pH-sensitive DNA cleaving agents: in situ activation by ring contraction of benzo-fused cyclobutanols
203. ChemInform Abstract: Tumescenamide C, an Antimicrobial Cyclic Lipodepsipeptide from Streptomyces sp.
204. HIGHLY ABSORPTIVE CURCUMIN IMPROVES LEFT VENTRICULAR DIASTOLIC FUNCTION REGARDLESS OF BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
205. A Novel Drug Delivery System of Oral Curcumin Markedly Improves Efficacy of Treatment for Heart Failure after Myocardial Infarction in Rats
206. Coarse integral imaging without pseudo image
207. Coarse integral volumetric imaging with flat screen and wide viewing angle
208. A Natural p300-Specific Histone Acetyltransferase Inhibitor, Curcumin, in Addition to Angiotensin-Converting Enzyme Inhibitor, Exerts Beneficial Effects on Left Ventricular Systolic Function After Myocardial Infarction in Rats
209. GBF1-Arf-COPI-ArfGAP-mediated Golgi-to-ER Transport Involved in Regulation of Lipid Homeostasis
210. KAGAKU TO SEIBUTSU
211. Innovative Preparation of Curcumin for Improved Oral Bioavailability
212. Inhibition of translation by cytotrienin A—a member of the ansamycin family
213. ChemInform Abstract: Novel Natural Products Open the Door of Chemical Biology and Medicinal Chemistry
214. ChemInform Abstract: Isolation and Biological Activity of a Novel Cytokine Modulator, Cytoxazone.
215. ChemInform Abstract: Cytoxazone: A Novel Cytokine Modulator Containing a 2-Oxazolidinone Ring Produced by Streptomyces sp.
216. Marine antifungal theonellamides target 3β-hydroxysterol to activate Rho1 signaling
217. ChemInform Abstract: Lucilactaene, a New Cell Cycle Inhibitor in p53-Transfected Cancer Cells, Produced by a Fusarium sp.
218. Novel Natural Products Open the Door of Chemical Biology and Medicinal Chemistry
219. ChemInform Abstract: Total Synthesis and Determination of the Absolute Configuration of FD-838, a Naturally Occurring Azaspirobicyclic Product.
220. Identification of Cytochrome P450s Required for Fumitremorgin Biosynthesis inAspergillus fumigatus
221. The Asymmetric Total Synthesis of (+)‐Cytotrienin A, an Ansamycin‐Type Anticancer Drug
222. Epoxyquinol B, a Naturally Occurring Pentaketide Dimer, Inhibits NF-κB Signaling by Crosslinking TAK1
223. ChemInform Abstract: Fungal Metabolite, Epoxyquinol B, Crosslinks Proteins by Epoxy‐Thiol Conjugation.
224. Fungal Metabolite, Epoxyquinol B, Crosslinks Proteins by Epoxy-thiol Conjugation
225. Epoxyquinol B Shows Antiangiogenic and Antitumor Effects by Inhibiting VEGFR2, EGFR, FGFR, and PDGFR
226. Enantio- and Diastereoselective Total Synthesis of (+)-Panepophenanthrin (I), a Ubiquitin-Activating Enzyme Inhibitor, and Biological Properties of Its New Derivatives.
227. RK‐95113, a New Angiogenesis Inhibitor Produced by Aspergillus fumigatus.
228. Enantio‐ and Diastereoselective Total Synthesis of (+)‐Panepophenanthrin, a Ubiquitin‐Activating Enzyme Inhibitor, and Biological Properties of Its New Derivatives
229. RK-95113, a New Angiogenesis Inhibitor Produced by Aspergillus fumigatus
230. A bridge between chemistry and biology
231. Concise Enantio- and Diastereoselective Total Syntheses of Fumagillol, RK-805, FR65814, Ovalicin, and 5-Demethylovalicin.
232. Synthesis and Biological Properties of New Phosmidosine Analogs Having anN-Acylsulfamate Linkage
233. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity
234. [Special Issue: Fact Databases and Freewares] RIKEN Natural Products Encyclopedia (RIKEN NPEdia),a Chemical Database of RIKEN Natural Products Depository (RIKEN NPDepo)
235. First Asymmetric Total Synthesis of Synerazol (I), an Antifungal Antibiotic, and Determination of Its Absolute Stereochemistry.
236. Enantio- and Diastereoselective Total Synthesis of EI-1941−1, −2, and −3, Inhibitors of Interleukin-1β Converting Enzyme, and Biological Properties of Their Derivatives
237. Epoxytwinol A, a Novel Unique Angiogenesis Inhibitor with C2 Symmetry, Produced by a Fungus
238. Determination of the Absolute Configuration of Lucilactaene, a Cell‐Cycle Inhibitor in p53‐Transfected Cancer Cells, by Asymmetric Total Synthesis.
239. Total Synthesis of Epoxyquinols A (I), B (II), and C (III) and Epoxytwinol A (IV) and the Reactivity of a 2H-Pyran Derivative as the Diene Component in the Diels—Alder Reaction.
240. Determination by Asymmetric Total Synthesis of the Absolute Configuration of Lucilactaene, a Cell-Cycle Inhibitor in p53-Transfected Cancer Cells
241. Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity
242. RKTS-33, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity
243. Total Synthesis of Epoxyquinols A, B, and C and Epoxytwinol A and the Reactivity of a 2H-Pyran Derivative as the Diene Component in the Diels−Alder Reaction
244. RK-805, an Endothelial-Cell-Growth Inhibitor Produced by Neosartorya sp., and a Docking Model with Methionine Aminopeptidase-2.
245. Structure—Activity Relationships of Epolactaene Derivatives: Structural Requirements for Inhibition of Hsp60 Chaperone Activity.
246. Synthesis of a biotin-conjugate of phosmidosine O-ethyl ester as a G1 arrest antitumor drug
247. Structure–activity relationship of phosmidosine: importance of the 7,8-dihydro-8-oxoadenosine residue for antitumor activity
248. ECH, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity
249. Novel Non‐Peptide Inhibitors Targeting Death Receptor‐Mediated Apoptosis.
250. Correction to: Different localization of lysosomal-associated membrane protein 1 (LAMP1) in mammalian cultured cell lines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.